scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Vincenzo Albanese | |
Enrico Tessitore | |||
Giuseppe Barbagallo | |||
Aldo Moraci | |||
Claudio Schonauer | |||
P2860 | cites work | The laminectomy membrane. Studies in its evolution, characteristics, effects and prophylaxis in dogs | Q28241712 |
Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy--a report of three cases. | Q33958971 | ||
Sir Victor Horsley (1857-1916): pioneer of neurological surgery | Q34113832 | ||
Ultrastructural aspects of interactions of platelets with microcrystalline collagen | Q36077469 | ||
A comparison of hemostatic agents in microvascular surgery | Q36636935 | ||
Intraoperative chemical hemostasis in neurosurgery | Q38161280 | ||
Assessment of an experimental bone wax polymer plus TGF-beta 1 implanted into calvarial defects | Q38550695 | ||
Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax. | Q38553642 | ||
The embolization of bone wax from sternotomy incisions | Q39240738 | ||
Comparative efficacy of topical hemostatic agents in a rat kidney model | Q39245049 | ||
Adverse effects of bone wax in surgery of the orbit | Q41051038 | ||
Effects of bone wax on rabbit cranial bone lesions | Q43592099 | ||
Tissue reaction to three subcutaneously implanted local hemostatic agents | Q43746061 | ||
Topical hemostatic agents to reduce bleeding from cancellous bone surfaces: a comparison of Gelfoam paste and bone wax. | Q44238814 | ||
Microcrystalline collagen. A new hemostatic agent | Q44460080 | ||
Hemostyptic effect of oxidized cellulose on blood platelets | Q44630940 | ||
In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms | Q44638410 | ||
Proceedings: Haemostasis and healing following median sternotomy | Q44740673 | ||
Effects of two hemostatic agents on osseous healing | Q44826121 | ||
Use of microfibrillar collagen as a topical hemostatic agent in brain tissue | Q48302907 | ||
Iatrogenic paraplegia caused by surgicel used for hemostasis during a thoracotomy: report of a case. | Q51550303 | ||
Microcrystalline collagen as a topical hemostatic agent for vascular surgery. | Q53923577 | ||
Effects of bone wax on bacterial clearance. | Q54053036 | ||
Topical hemostatic agents for bone bleeding in humans. A quantitative comparison of gelatin paste, gelatin sponge plus bovine thrombin, and microfibrillar collagen | Q67015833 | ||
Effect of local hemostatics on platelet aggregation | Q67956715 | ||
Osseous regeneration in the presence of four common hemostatic agents | Q68136165 | ||
Hemostasis in neurosurgical operations. A comparative study between collagen fleece (Lyostypt) and a gelatine sponge (Marbagelan) | Q68138884 | ||
Hemostatic agents: brain tissue reaction and effectiveness. A comparative animal study using collagen fleece and oxidized cellulose | Q69080370 | ||
Microcrystalline collagen used in experimental splenic injury. A new surface hemostatic agent | Q69134588 | ||
Osseous reactions to three hemostatic agents | Q69833589 | ||
[Evaluation of the efficacy of a new generation of hemostatic collagen compresses. Results of a multicenter prospective study in visceral surgery and neurosurgery] | Q70174802 | ||
Effects of oxidized cellulose and microfibrillar collagen on infection | Q70277851 | ||
Reaction of the human tibia to bone wax | Q70313616 | ||
[Use of a new antihaemorrhagic agent in neurosurgery. Trial in 35 cases (author's transl)] | Q70435392 | ||
Gelfoam paste in experimental laminectomy and cranial trephination: hemostasis and bone healing | Q70766783 | ||
Experimental and Clinical Experiences with Collagen Fleece as a Hemostatic Agent | Q70768395 | ||
Control of bone bleeding during Cloward procedure. Technical note | Q71128008 | ||
Control of bone bleeding | Q71188290 | ||
Surgical bone wax causing epistaxis | Q71322767 | ||
The use of Gelfoam paste in anterior cervical fusion | Q71766321 | ||
The effect of bone wax on the healing of experimental rat tibial lesions | Q72379178 | ||
Complications secondary to the use of standard bone wax in seven patients | Q72635235 | ||
A comparison between 2 absorbable hemostatic agents: gelatin sponge (Spongostan®) and oxidized regenerated cellulose (Surgicel®) | Q72750556 | ||
Comparative in vitro analysis of topical hemostatic agents | Q73048839 | ||
A retroperitoneal tumor as a late complication of the use of bone wax | Q73262446 | ||
Iatrogenic quadriplegia and bone wax. Case illustration | Q73673727 | ||
New absorbable hemostatic bone wax; experimental and clinical studies | Q75580304 | ||
Bone wax as a cause of a foreign body granuloma in a cranial defect: a case report | Q79322552 | ||
P921 | main subject | cellulose | Q80294 |
P304 | page(s) | S89-96 | |
P577 | publication date | 2004-06-22 | |
P1433 | published in | European Spine Journal | Q15763992 |
P1476 | title | The use of local agents: bone wax, gelatin, collagen, oxidized cellulose | |
P478 | volume | 13 Suppl 1 |
Q42001245 | A moldable putty containing silk fibroin yolk shell particles for improved hemostasis and bone repair |
Q82592410 | A novel hemostatic delivery device for thrombin: Biodegradable poly(D,L‐lactide‐co‐glycolide) 50:50 microspheres |
Q37384158 | A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial |
Q64056505 | A strongly adhesive hemostatic hydrogel for the repair of arterial and heart bleeds |
Q57138488 | Analysis of bone healing with a novel bone wax substitute compared with bone wax in a porcine bone defect model |
Q35125534 | Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. |
Q53485248 | Antimicrobial effect of OKCEL® H-D prepared from oxidized cellulose. |
Q37786596 | At the nanoscale: nanohemostat, a new class of hemostatic agent |
Q36452891 | Atomic layer deposition of titanium dioxide on cellulose acetate for enhanced hemostasis. |
Q64255547 | Bespoke GelFoam Wafers: A Practical and Inexpensive Alternative to Oxycel for Hemostasis during Neurosurgery |
Q92723432 | Blood management in fast-track orthopedic surgery: an evidence-based narrative review |
Q88647930 | Bone Wax in Neurosurgery: A Review |
Q48351997 | Bone wax extrusion through postauricular wounds: A case series. |
Q36811967 | Bone-wax granuloma after femoral neck osteoplasty |
Q59298706 | Cellulose-based materials as scaffolds for tissue engineering |
Q42105897 | Closing the medullary canal after retrograde nail removal using a bioabsorbable bone plug: technical tip. |
Q38796881 | Comparison of the efficacy of two local haemostatic agents. |
Q36293339 | Does bone wax induce a chronic inflammatory articular reaction? |
Q38424080 | Effectiveness of Surgicel® (Fibrillar) in patients with colorectal endoscopic submucosal dissection |
Q50965594 | Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. |
Q37368556 | Efficacy of TachoSil, a Fibrin-Based Hemostat, for Anterior Lumbar Spine Surgery |
Q35676038 | Evaluation of the biological tolerability of the starch-based medical device 4DryField® PH in vitro and in vivo a rat model |
Q37426417 | Experimental investigation of the effects of a blood stopper agent (ankaferd blood stopper) on bone surfaces |
Q47642862 | Hemocompatibility of Ca2+ -Crosslinked Nanocellulose Hydrogels: Toward Efficient Management of Hemostasis |
Q51182641 | Hemostatic action of polyurethane foam with 55% polyethylene glycol compared to collagen and gelatin. |
Q38168784 | Hemostatic strategies for traumatic and surgical bleeding |
Q53485287 | How hemostatic agents interact with the coagulation cascade. |
Q47850600 | In vitro and in vivo evaluation of the duck's feet collagen sponge for hemostatic applications |
Q88047211 | In vivo assessment of new resorbable PEG-PPG-PEG copolymer/starch bone wax in bone healing and tissue reaction of bone defect in rabbit model |
Q84705227 | In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin |
Q36825850 | Infection rates and healing using bone wax and a soluble polymer material |
Q55026023 | Injecting hemostatic matrix in the path of biopsies: efficacy, potential complications, and the management of such complications. |
Q40876320 | Intraventricular Bone Wax as Cause of Recurrent Cerebrospinal Fluid Infection: A Neuroradiologic Pitfall |
Q36254187 | Isolation, Characterization and Evaluation of Collagen from Jellyfish Rhopilema esculentum Kishinouye for Use in Hemostatic Applications |
Q47983865 | Local tissue reaction after the application of topical hemostatic agents in a rat partial nephrectomy model |
Q33635919 | Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing |
Q41691782 | Oxidized Cellulose (Surgicel) Causing Postoperative Cauda Equine Syndrome |
Q37840280 | Peri-operative management of ophthalmic patients taking antithrombotic therapy |
Q33818396 | Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now? |
Q52662343 | Preoperative embolization and local hemostatic agents in palliative decompression surgery for spinal metastases of renal cell carcinoma. |
Q35076159 | Preoperative embolization versus local hemostatic agents in surgery of hypervascular spinal tumors |
Q47753208 | Preparation and characterization of PEG-PPG-PEG copolymer/pregelatinized starch blends for use as resorbable bone hemostatic wax. |
Q41912079 | Preparation of Chitosan-Based Hemostatic Sponges by Supercritical Fluid Technology |
Q64078446 | Processing of collagen based biomaterials and the resulting materials properties |
Q39300112 | Processing, characterization and hemostatic mechanism of a ultraporous collagen/ORC biodegradable composite with excellent biological effectiveness |
Q55004941 | Properties of collagen-based hemostatic patch compared to oxidized cellulose-based patch. |
Q83179520 | Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model |
Q34706866 | Surgical Materials: Current Challenges and Nano-enabled Solutions. |
Q33774658 | The effect of three hemostatic agents on early bone healing in an animal model |
Q33735705 | The effects of surgicel and bone wax hemostatic agents on bone healing: An experimental study |
Q56967388 | The efficacy and safety of chitosan dextran gel in a burr hole neurosurgical sheep model |
Q64891146 | Translation of bone wax and its substitutes: History, clinical status and future directions. |
Q90348003 | Usage of Bone Wax to Facilitate Percutaneous Endoscopic Cervical Discectomy Via Anterior Transcorporeal Approach for Cervical Intervertebral Disc Herniation |
Q37696670 | Use of Gelatin Sponge Affects Postoperative Morbidity In Cesarean Section Patients |
Q35145625 | Use of bone wax is related to increased postoperative sternal dehiscence |
Q47655282 | Yolk shell nanocomposite particles as bioactive bone fillers and growth factor carriers. |
Q79610949 | [Local and systemic hemostasis in surgery] |
Search more.